Hematology
From the Journals
Small-volume blood sample tubes may reduce anemia and transfusions in intensive care
“Here’s an opportunity to move the needle on reducing anemia in hospitalized patients, where the benefit also doesn’t come at a cost.”
From the Journals
Unexplained collapse unveils rare blood disorder
Acquired TTP often appears to arise in connection with either an immune trigger, such as a viral infection, or immune dysregulation associated...
From the Journals
Trial shows utility of small-volume blood collection tubes
A clinical trial in Canada has found that small-volume blood collection tubes equal standard-volume tubes for specimen capture while reducing...
News
FDA approves first tx for rare, deadly clotting disorder
First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.
Pearl of the Month
My favorite iron pearls
Iron supplements can treat fatigue, restless legs syndrome, and possibly thinning hair.
From the Journals
Young girls, women are at high risk of iron deficiency: Study
Current screening guidelines for iron levels in girls and women may be flawed.
Latest News
Consider mental health and social factors in management of sickle cell disease
Screen sickle cell disease patients for depression and mental health issues, especially those reporting higher levels of pain.
From the Journals
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
Latest News
Guide explains nonsurgical management of major hemorrhage
Bleeding affects everybody in medicine, from family doctors in smaller institutions who work in emergency departments to obstetricians and...
From the Journals
“Terrific progress”: Adding blinatumomab for infant leukemia
Immunotherapy plus chemotherapy improves outcomes and may soon become first-line treatment for a rare pediatric blood cancer.
Feature
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.